Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Yogabasert bevegelser for primærhodepine (migrene og/eller klyngehodepine) - YOURHEAD

18. september 2026 oppdatert av: Marian Papp, Karolinska Institutet

Yogabasert bevegelsestrening ukentlig (online direkte eller ansikt til ansikt) for primære hodepiner

Brief Summary:

Migraine and/or Cluster Headache: Study Overview

**Background:** Migraine and cluster headache are two primary headache disorders that significantly impact quality of life and functionality in those affected. According to the WHO's recurring burden of disease reports, migraine is among the neurological conditions responsible for the highest number of years lost due to illness. The headaches associated with migraine and cluster headache range from moderate to severe and cause great suffering. Available treatments do not work for everyone and are often associated with adverse side effects. Physical activity has been shown in several studies to have a positive effect on headache. Given the high prevalence of mental health issues, stress, and sleep problems within this patient group, relaxation and low-intensity exercise such as yoga-based movements (YB) could potentially help individuals improve sleep and well-being, while also providing some preventive effect on headaches.

**Hypothesis:**

Individuals with severe migraine or cluster headache have a strong need for new treatment options. Alternative therapies such as yoga-based exercises, when combined with standard medical treatment as per clinical guidelines, may positively impact:

Headache symptoms, Sleep quality and Overall life quality

  • Purpose and Goals:** This randomized controlled study aims to evaluate the effect of a web-based yoga (YB) or live face to face (FTF) intervention in individuals suffering of primary headaches-mainly chronic migraine and/or cluster headache. The study will assess the effect of YB on health-related changes in headache frequency, intensity, and duration associated with primary headache conditions, with a focus headache frequency. A secondary objective is to analyze quality of life, sleep quality, mental health as depression and anxiety. The RCT will also measure objective sleep and biomarkers. We are now summarizing the effects after a pilot study.
  • Relevance for the Patient Group:** The core objective of the project is to determine whether yoga-based exercises can serve as a complementary treatment to enhance quality of life and health in patients with severe primary headache. To ensure equal healthcare access, this intervention will be delivered in digital format and/or FTF to optimize availability and expand care for individuals with primary headache disorders. These efforts aim to improve life quality and well-being in a vulnerable patient population. Headache conditions often affect individuals in their most productive years, and many live with symptoms for decades. Both work and private life are frequently disrupted, resulting in sick leave and social isolation. Close relatives are also affected, as those suffering from headaches require more recovery time to cope with daily life. With this proposed project, we aim to use physical yoga, rooted in holistic traditional medicine, to help individuals with severe primary headache achieve better physical and mental health-particularly improved sleep quality, which in turn enhances overall life quality.

Studieoversikt

Detaljert beskrivelse

Detailed Description:

Current Situation

Migraine and cluster headache are two neurological conditions characterized by recurrent attacks of severe headache. Approximately 14% of the population is estimated to suffer from migraines, while cluster headaches have a prevalence of around 0.1%. The phenotype is marked by unilateral headache attacks lasting approximately 15 minutes to three hours for cluster headache and three hours to three days for migraine. Acute treatment for migraines and cluster headaches typically involves triptans or oxygen therapy to break the attacks, and prophylactic treatment when needed.

Studies have shown that individuals with headaches experience significant impacts on quality of life and often suffer from mental health issues. Research from Karolinska Institutet and the Headache Centre in Copenhagen has demonstrated sleep disturbances among individuals with cluster headaches. Sleep-related diagnoses are also frequently reported in individuals with migraine, and migraine is more prevalent among shift workers compared to non-shift workers. Collectively, these studies indicate a strong connection between sleep problems, mental health, and headache.

The disease burden in high-frequency migraine, chronic migraine, and cluster headache is substantial, and additional alternative treatments are needed alongside standard pharmaceutical therapies. Individuals with these headache types report higher sick leave rates than the general population, and cluster headache sufferers with concurrent mental health issues show increased prevalence for long-term sick leave and disability pension.

Role of Yoga-Based Exercises (YB)

Yoga-based exercises have gained attention in healthcare and are used as complementary treatments for various conditions. Reviews and meta-analyses show effects on stress symptoms, mental states such as sleep disturbances and depression. Web-based yoga interventions have also improved sleep and stress, as well as chronic neck and back pain. Improvements have been observed in endothelial function and inflammation markers.

A review article from China indicates that physical yoga (similar to the planned intervention) appears to reduce headache intensity, duration, and frequency. Previous studies show reductions in migraine headache following yoga interventions, and smaller Indian studies report effects on headache intensity and quality of life in migraine. Research in Western contexts is limited and studies conducted in India tend to show more positive results-possibly due to higher treatment dosages or contextual influences, including placebo or Hawthorne effects.

The American Migraine Foundation recommends yoga-based exercises as a complementary treatment for stress reduction and migraine symptom management, as stress is a common migraine trigger. There is currently no research on yoga-based interventions for cluster headaches, and only a few published studies on migraines.

Traditional Medical Practices

Indian traditional medicine recommends specific exercises (e.g., inversions) for treating headaches, high blood pressure, and improving sleep quality and insomnia. Inversions appear to activate deep brain regions related to sleep and have a calming effect. Sleep disorders often trigger migraines and vice versa. Melatonin rhythms, which may be unstable in headache conditions, often stabilize following yoga-based interventions.

Studietype

Intervensjonell

Registrering (Antatt)

80

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Huddinge, Sverige, 141 83
        • Rekruttering
        • Karolinska Institutet
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marian E Papp, PhD, post-doc

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Diagnosed chronic migraine and/or cluster (Hortons) headache
  • Men and women 18-65 years
  • Diagnosed with chronic/high frequency migraine (≥15 headache days/month with at least ≥8 with migraine)
  • Diagnosed with chronic cluster head ache (i.e shorter remission than 3 months per year), diagnosed according to ICHD-III criteria.
  • Ability to perform yoga based moments and to give consent.
  • Internet connection with computer/ipad/mobile to perform digitally/tele-health instructions
  • Willing to use wristwatch for actigraphy
  • Willing to leave blood samples in laboratory

Exclusion Criteria:

  • Recent or planned operations during the last 6 weeks
  • Drug dependence, alcohol dependence, mental disorders as psychosis, bipolar disorder, anxiety as PTSD etc)
  • Parallel enrollment in other clinical trails
  • Unmedicated high blood pressure, heart disease as heart failure
  • Non Swedish speaking
  • Not able to perform low intensity exercise at home or FTF (face to face) - both online or live.
  • Participants unsure to participate due to drug addiction or other causes
  • Disorientation and not able to inform regarding other serious conditions

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Ingen inngripen: Ingen intervensjon - venteliste
Eksperimentell: Intervention yogic exercises

Yogabased movements (online live or face to face) for primary headaches

8-12 weeks intervention using digital och face to face yogic exercises

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Headache diary - frequency of headaches
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

Headache frequency (number of days a month and number of attacks per day)

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Headache diary - intensity of headaches
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

Headache intensity/pain using a visual analog scale (VAS-scale) where 0 is no pain and 100 is maximal pain.

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
Actrigraph - sleep quality and activity level
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

Objective measurement of sleep using actigraphs worn on the wrist for one week at baseline and one week at the end of the study. ActTrust 2, Actiwatch or another brand is a wristwatch-like device that measures acceleration. By measuring acceleration at the wrist, an estimate of physical activity can be obtained, from which an activity pattern for a participant can be produced. This provides an objective measure of sleep duration and sleep quality. The sleep watch measures activity in general using tri-axial raw data accelerometer along with environmental light and temperature sensors and sleep is part of this through looking at reduced activity.

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
Dysfunctional Beliefs and attitudes about sleep (DBAS-10)
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

Measures sleep related cognitions in a VAS (visual analog)-scale. The scale identifies specific, irrationell and affective thoughts that can disturb insomnia and evaluated sleep related cognitions. Factor I (5 items) was labeled Beliefs about the Immediate Negative Consequences of Insomnia. Factor II (3 items) was labeled Beliefs about the Long-term Negative Consequences on Insomnia. Factor III was labeled Beliefs about the Need for Control Over Insomnia (2 items). People with insomnia have higher DBAS scores than good sleepers. Administration time 10 minutes

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
Perceived stress Questionnaire (PSQ-30)
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

PSQ includes 30 questions and measures stress symptoms in adults. It includes a Likertscale with 4 options. Where 1= almost never; 2= sometimes;3=oftan;4=most of the time Scoring Total score = summary of all items Reversed scoring for questions: 1, 7, 10, 13, 17, 21, 25, 29 PSQ Index (totalscore-30)/90 https://onlinelibrary.wiley.com/doi/abs/10.1002/smi.946

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
Nijmegen Dysfunctional breathing scale
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

The Nijmegen Questionnaire (often called the Nijmegen Dysfunctional Breathing Scale) is a validated screening tool designed to identify symptoms of dysfunctional breathing, particularly hyperventilation/overbreathing syndrome. It consists of 16 symptom items scored on a 0-4 scale, with higher scores indicating greater respiratory distress. A total score above 19-23 suggests clinically relevant breathing dysfunction. 16 items covering common symptoms such as chest pain, dizziness, blurred vision, shortness of breath, and feelings of tension.

Each item is rated on a 5-point Likert scale: 0 = Never, 1 = Rarely, 2 = Sometimes, 3 = Often, 4 = Very often.

19 points: Indicates possible dysfunctional breathing or hyperventilation. 23 points: Stronger indication of hyperventilation syndrome

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
Neck-pain - number of days a month
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

Number of neck-pain days month (number of days with neck-pain).

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
The Migraine Disability Assessment Test (MIDAS)
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

MIDAS measures measure the impact the headaches have on quality of life 0-5 points - Grade 1=Little or No Disability, 6-10 points - Grade 2=mild disability, 11-20 points - Grade 3= moderate disability, 21+ points - Grade 4 = severy disability If MIDAS Score is 6 or more contact with doctor i suggested https://headaches.org/wp-content/uploads/midas.pdf

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
Intensity of neck-pain
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

One single question of the intensity of neck-pain intensity/pain using a visual analog scale (VAS-scale) where 0 is no pain and 10 is maximal pain.

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks
Karolinska Sleep questionnarie (KSQ) - subjective sleepiness
Tidsramme: Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

KSQ includes 18 questions - on a 6 graded likert scale between 0-5, where 0 = never and 5 = always. Some reversed scoring. One is not using total scores for the KSQ. It is also possible to calculate index-values.

There are cut-off values to compare with a healthy population or other studies with the same disorder. There are cut-offs for KSQ for normal swedish population but also using the 90:e percentile for a swedish population (different for men and women)

Baseline (day 1 of the study) and 8-12 weeks after the end of the intervention, follow-up for up to 24 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. mai 2026

Primær fullføring (Antatt)

1. desember 2027

Studiet fullført (Antatt)

30. desember 2027

Datoer for studieregistrering

Først innsendt

8. desember 2025

Først innsendt som oppfylte QC-kriteriene

9. januar 2026

Først lagt ut (Faktiske)

16. januar 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

23. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. september 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere